Georgia Basil

Georgia Basil, RPh, is a seasoned clinical account executive with extensive experience in the pharmaceutical industry, currently working at ANI Pharmaceuticals, Inc. since February 2024 and also as a specialty account manager within the rare disease business unit at Amgen since October 2023, following Amgen's acquisition of Horizon Therapeutics. Georgia's background includes a significant role at Horizon from January 2016 to October 2023, managing relationships with healthcare professionals and serving as a clinical expert in gout treatments. Previous positions include key account manager at Crealta Pharmaceuticals, renal sales specialist at Keryx Biopharmaceuticals, and area sales manager at Auxilium Pharmaceuticals and other companies, with a focus on educating physicians, facilitating sales processes, and ensuring compliance with reimbursement procedures. Georgia holds a Doctorate in Pharmacy from the University of Florida and a Registered Pharmacist degree from St. John's University.